Former President, Degenerative Diseases(5) · Celularity Inc (CELU)

Stephen Brigido

FY2025 is the first fiscal year CompBrief holds for Stephen Brigido as a named executive officer of Celularity; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$519,465

Salary $465,625Stock awards $0

3rd of 3 named executive officers at Celularity by FY2025 total.

3 named officers on file for Celularity, FY2025

Stephen Brigido’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Celularity’s whole pay program stands against its peers

  • Celularity’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CELU→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed November 10, 2026 (DEF 14A).

Free

Get Stephen Brigido’s full pay file as a PDF — free

More than this page: up to 10 years of Stephen’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Stephen Brigido compensation by year

Celularity Summary Compensation Table · the one fiscal year held
In US dollars, as Celularity reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$465,625
Bonus$0
Stock awards$0
Option awards$0
Non-equity incentive$0
Pension and deferred compensation$0
All other$53,840
Total$519,465

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Celularity Inc DEF 14A filed November 10, 2026, accession 0001493152-26-050988, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Celularity Inc filed document, accession 0001493152-26-050988. Every figure is read from that document and cited to the page and table it appears in. Filed November 10, 2026.

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU821$911—
Option802—$101.60
Option821—$0.00

Per the Outstanding Equity Awards at Fiscal Year-End table in Celularity Inc's FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Celularity’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Robert HaririChief Executive Officer$650,651
John HainesFormer Senior Executive Vice President, Chief Administrative Officer and Corporate Secretary(4)$535,052
Stephen Brigido · this pageFormer President, Degenerative Diseases(5)$519,465

The full Celularity compensation record

free company brief

This page is one person within Celularity's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Celularity's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Stephen Brigido's compensation dossier · One-time report. No refunds.